Diabetes Epidemiology in the COVID-19 Pandemic
Diabetes Epidemiology in the COVID-19 Pandemic
复制标题
DOI：
10.2337/dc20-1295
复制
发表时间：
2020-08-01
期刊：
影响因子：
16.2
通讯作者：
Juraschek, Stephen P.
中科院分区：
文献类型：
--
作者：
Selvin, Elizabeth;Juraschek, Stephen P.
糖尿病已被确定为2019冠状病毒病（COVID-19）住院患者死亡率和进展为急性呼吸窘迫综合征（ARDS）的重要风险因素。然而，最近关于这一主题的许多报告反映了匆忙的方法，缺乏仔细的流行病学设计，实施和分析。先前研究的特点给我们理解糖尿病和其他潜在合并症对COVID-19预后的真正贡献带来了问题。在这一观点中，我们讨论了解释当前糖尿病和COVID-19文献的一些挑战，并讨论了未来流行病学研究的机会。我们认为，COVID-19大流行是流行病学领域的一个决定性时刻，糖尿病流行病学应发挥重要作用。
Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comorbidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role.